1-5 of 5
Aart H. Bootsma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria

Adrienne A.M. Zandbergen, MD, PHD, Liffert Vogt, MD, Dick de Zeeuw, MD, PHD, Steven W.J. Lamberts, MD, PHD, Rob J.T.H. Ouwendijk, MD, PHD, Marinus G.A. Baggen, MD, PHD, Aart H. Bootsma, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(12):3119–3121
https://doi.org/10.2337/dc07-0960
Published: 01 December 2007
View article titled, Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria
Open the PDF for Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria in another window
Journal Articles

Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease

Adrienne A.M. Zandbergen, MD, Eric J. Sijbrands, MD, PHD, Steven W. Lamberts, MD, PHD, Aart H. Bootsma, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(8):1851–1855
https://doi.org/10.2337/dc06-0287
Published: 01 August 2006
View article titled, Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease
Open the PDF for Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease in another window
Journal Articles

Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients: A review

Loes C. Lanting, MSC, Inez M.A. Joung, PHD, Johan P. Mackenbach, PHD, MD, Steven W.J. Lamberts, PHD, MD, Aart H. Bootsma, PHD, MD
Journal: Diabetes Care
Diabetes Care 2005;28(9):2280–2288
https://doi.org/10.2337/diacare.28.9.2280
Published: 01 September 2005
View article titled, Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients: <subtitle>A review</subtitle>
Open the PDF for Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients: <subtitle>A review</subtitle> in another window
Includes: Supplementary data
Journal Articles

Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes : A potential mechanism to lower plasma triglycerides

Geesje M. Dallinga-Thie, PHD, Ingrid I.L. Berk-Planken, MD, PHD, Aart H. Bootsma, MD, PHD, Hans Jansen, PHD, on behalf of the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(6):1358–1364
https://doi.org/10.2337/diacare.27.6.1358
Published: 01 June 2004
View article titled, Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes : <subtitle>A potential mechanism to lower plasma triglycerides </subtitle>
Open the PDF for Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes : <subtitle>A potential mechanism to lower plasma triglycerides </subtitle> in another window
Journal Articles

Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: Effect of sex and the LIPC promoter variant

Ingrid I.L. Berk-Planken, MD, Nicoline Hoogerbrugge, MD, PHD, Ronald P. Stolk, MD, PHD, Aart H. Bootsma, MD, PHD, Hans Jansen, MRBC, PHD, on behalf of the DALI study group
Journal: Diabetes Care
Diabetes Care 2003;26(2):427–432
https://doi.org/10.2337/diacare.26.2.427
Published: 01 February 2003
View article titled, Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: <subtitle>Effect of sex and the <em>LIPC</em> promoter variant</subtitle>
Open the PDF for Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: <subtitle>Effect of sex and the <em>LIPC</em> promoter variant</subtitle> in another window